![Janek Paul André Frantzén](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Janek Paul André Frantzén
Directeur/Membre du Conseil chez BonAlive Biomaterials Oy
Profil
Janek Paul André Frantzén is currently a Director at BonAlive Biomaterials Oy.
He obtained a doctorate degree from the University of Bergen in 2001.
Postes actifs de Janek Paul André Frantzén
Sociétés | Poste | Début |
---|---|---|
BonAlive Biomaterials Oy
![]() BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland. | Directeur/Membre du Conseil | - |
Formation de Janek Paul André Frantzén
University of Bergen | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
BonAlive Biomaterials Oy
![]() BonAlive Biomaterials Oy Medical SpecialtiesHealth Technology BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland. | Health Technology |